Table 1 Clinicopathological parameters in a cohort of prostate cancer patients.

From: Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression

Clinical parameters

No. of patients

p value

All patients

100

 

Age (years)

 

0.0067

  < 65

38

 

  ≥ 65

62

 

Pre-operative PSA level (ng/mL)

 

0.0269

 Low (PSA < 10 ng/mL)

58

 

 High (PSA ≥ 10 ng/mL)

42

 

Biochemical recurrence (PSA > 0.2 ng/mL)

 

0.0001

 PSA > 0.2 ng/mL

28

 

 PSA < 0.2 ng/mL

72

 

Metastasis

0.0041

 M0

93

 

 M1

7

 

Gleason grade

0.0003

 6

30

 

 7

45

 

 8

10

 

 9

15

 

Stage

0.0067

 I

30

 

 II

33

 

 III

12

 

 IV

10

 

 V

15